Your browser doesn't support javascript.
loading
PROTAC: targeted drug strategy. Principles and limitations.
Koroleva, O A; Dutikova, Yu V; Trubnikov, A V; Zenov, F A; Manasova, E V; Shtil, A A; Kurkin, A V.
Afiliação
  • Koroleva OA; Department of Chemistry, Lomonosov Moscow State University, Build. 3, 1 Leninskie Gory, 119991 Moscow, Russian Federation.
  • Dutikova YV; Patent & Law Firm "A. Zalesov and Partners", Build. 9, 2 ul. Marshala Rybalko, 123060 Moscow, Russian Federation.
  • Trubnikov AV; Department of Chemistry, Lomonosov Moscow State University, Build. 3, 1 Leninskie Gory, 119991 Moscow, Russian Federation.
  • Zenov FA; Department of Chemistry, Lomonosov Moscow State University, Build. 3, 1 Leninskie Gory, 119991 Moscow, Russian Federation.
  • Manasova EV; Department of Chemistry, Lomonosov Moscow State University, Build. 3, 1 Leninskie Gory, 119991 Moscow, Russian Federation.
  • Shtil AA; Department of Chemistry, Lomonosov Moscow State University, Build. 3, 1 Leninskie Gory, 119991 Moscow, Russian Federation.
  • Kurkin AV; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Build. 15, 24 Kashirskoe shosse, 115478 Moscow, Russian Federation.
Russ Chem Bull ; 71(11): 2310-2334, 2022.
Article em En | MEDLINE | ID: mdl-36569659
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Russ Chem Bull Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Russ Chem Bull Ano de publicação: 2022 Tipo de documento: Article